| Literature DB >> 30251643 |
Mathias Mertz-Petersen1, Thomas B Piper1, Jakob Kleif1, Linnea Ferm1, Ib Jarle Christensen1, Hans J Nielsen2.
Abstract
Implementation of population screening for colorectal cancer by direct colonoscopy or follow-up colonoscopy after a positive fecal blood test has challenged the overall capacity of bowel examinations. Certain countries are facing serious colonoscopy capacity constraints, which have led to waiting lists and long-time latency of follow-up examinations. Various options for improvement are considered, including increased cut-off values of the fecal blood tests. Results from major clinical studies of blood-based, cancer-associated biomarkers have led to focus, however, on a triage concept for improved selection to colonoscopy. The triage test may include subject age, concentration of hemoglobin in a feces test and a combination of certain blood-based cancer associated biomarkers. Recent results have indicated that triage may reduce the requirements for colonoscopy by around 30%. Such results may be advantageous for the capacity, the heath budgets and in particular, the subjects, who do not need an unnecessary, unpleasant and risk-associated bowel examination.Entities:
Keywords: Biomarkers; Blood test; Colonoscopy; Colorectal cancer; Screening; Triage
Mesh:
Substances:
Year: 2018 PMID: 30251643 DOI: 10.1016/j.ejso.2018.06.013
Source DB: PubMed Journal: Eur J Surg Oncol ISSN: 0748-7983 Impact factor: 4.424